Daehan Synthet (003830) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Daehan Synthet KRW 147,600, price KRW 109,800, upside +34.4%, quality 47 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Daehan Synthet for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 93,463 KRW – 162,551 KRW · fair‑value band 103,320 KRW – 188,070 KRW · the 109,800 KRW price screens below the 147,600 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Daehan Synthet in your weekly email
Every Wednesday you see whether Daehan Synthet is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Daehan Synthetic Fiber Co., Ltd. manufactures and sells polyester yarns in South Korea and internationally. The company offers specialty and regular polyester yarns. It sells its products under the Acepora brand. Daehan Synthetic Fiber Co., Ltd. was founded in 1963 and is headquartered in Seoul, South Korea.
Stock analysis
Daehan Synthet (003830) currently trades at 109,800 KRW, while our model-based Fair Value estimate is 147,600 KRW, implying the stock looks roughly 25.6% undervalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of 440,517 KRW per share, and 6 of the 8 models we run sit above the 109,800 KRW price.
Bear case: the DCF Models group reads lowest at 69,228 KRW, and 2 of the 8 models stay below the price. Evidence for this calculation is medium.
Scenario range: 103,320 KRW (bear) to 188,070 KRW (bull), the price of 109,800 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 47/100 (below-average quality), in the Consumer Cyclical sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Daehan Synthet reported revenue of 108B KRW in FY2025 versus 117B KRW in FY2021, a compound −2.0%/yr. Reported net income was 9.6B KRW in FY2025, compounding −20.8%/yr from FY2021.
Key figures
Market cap 119B KRW (≈ $87.3M) · P/S ratio 1.15 · Dividend yield 0.7% · Net margin 8.9% · Return on equity 1.8% · Return on assets (EBIT) 0.3% · Operating margin −2.4% · Revenue (TTM) 106B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
The share trades about 22% below its 52-week high and 6% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at −21% fair-value upside, at 34%, 003830 screens cheaper than that median.
Fair Value models
Bear 103,320 KRWFair Value 147,600 KRWBull 188,070 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.35/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−12.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−10.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.5%
Start year 2020 (pandemic). Over 10 years: −2.2% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.6%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−14.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year−15.0%
Dividend (yield on the price)0.7%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.4% → −7%
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Textile Manufacturing · 344 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Daehan Synthet Fair Value". https://www.fairvalue-calculator.com/stock/003830
Frequently asked questions
Is Daehan Synthet (003830) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 147,600 KRW versus a price of 109,800 KRW, about +34% upside (undervalued).
What is the fair value of 003830?
Our model-based fair value for Daehan Synthet is 147,600 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 109,800 KRW.
What is the quality score of 003830?
Daehan Synthet has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Daehan Synthet (003830)?
Our model-based price target is the fair value of 147,600 KRW (as of Sep 24, 2026) from 8 valuation models. Cautious scenario 103,320 KRW, optimistic scenario 188,070 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Daehan Synthet stock forecast for 2026?
Our models put fair value at 147,600 KRW, about +34% upside versus a price of 109,800 KRW (undervalued). Cautious scenario 103,320 KRW, optimistic scenario 188,070 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Daehan Synthet (003830)?
Daehan Synthet reported trailing-twelve-month revenue of about 106B KRW (latest available figure, as of Sep 24, 2026).
Does Daehan Synthet pay a dividend?
Daehan Synthet currently shows a dividend yield of about 0.68% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Daehan Synthet (003830)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Daehan Synthet it is 147,600 KRW per share (as of Sep 24, 2026), against a price of 109,800 KRW. It is the blended result of 8 valuation models (cash flow, earnings, asset, dividend).
Is Daehan Synthet stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 003830 trades below its calculated fair value: price 109,800 KRW, fair value 147,600 KRW, a gap of about +34% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 003830?
No. The price is what the market pays today (109,800 KRW); the fair value is what the company's own numbers justify (147,600 KRW). For Daehan Synthet the two are 37,800 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Daehan Synthet worth?
The market values Daehan Synthet at about 119B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 109,800 KRW; our models calculate a fair value of 147,600 KRW per share.
What do the bullish and bearish scenarios say about 003830?
Our models span a range for Daehan Synthet: cautious scenario 103,320 KRW, base 147,600 KRW, optimistic 188,070 KRW per share (as of Sep 24, 2026, price 109,800 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Daehan Synthet (003830)?
Balance-sheet figures for Daehan Synthet (as of Sep 24, 2026): return on equity 1.8%. They feed the Quality Score of 47/100, which measures business quality independently of the share price.
How far is 003830 from its 52-week high?
Daehan Synthet trades at 109,800 KRW, about 22% below its 52-week high of 140,549 KRW and 6% above the low of 103,900 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 147,600 KRW is for.
Which stocks are comparable to Daehan Synthet?
From the same area (Consumer Cyclical) we also value Shenzhou International Group, Tongkun Group, Inner Mongolia ERDOS Resources Co, K.P.R. Mill Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Daehan Synthet stock attractive at the current price?
The data as of Sep 24, 2026: price 109,800 KRW, calculated fair value 147,600 KRW (+34%), Quality Score 47/100, from 8 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 003830 calculated?
We run Daehan Synthet through 8 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 147,600 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Daehan Synthet currently trades 34 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Daehan Synthet (003830)?
The closing price on Sep 23, 2026 was 109,800 KRW. Our model-based fair value is 147,600 KRW, about +34% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Daehan Synthet right now?
Solid quality (47/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (103,320 KRW to 188,070 KRW) leaves room in how you read the outcome.
Key figures of Daehan Synthet
How large is the market capitalisation of Daehan Synthet (003830)?
The market capitalisation of Daehan Synthet is 119B KRW (≈ $87.3M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Daehan Synthet (003830)?
The price-to-sales ratio of Daehan Synthet is 1.15 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Daehan Synthet (003830)?
The dividend yield of Daehan Synthet is 0.7%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Daehan Synthet (003830)?
The net margin of Daehan Synthet is 8.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Daehan Synthet (003830)?
The return on equity (ROE) of Daehan Synthet is 1.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Daehan Synthet (003830)?
On an EBIT basis the return on assets of Daehan Synthet is 0.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Daehan Synthet (003830)?
The operating margin of Daehan Synthet is −2.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Daehan Synthet (003830)?
Revenue at Daehan Synthet is growing −7.7% versus a year earlier (3y avg −10.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Daehan Synthet (003830)?
Earnings per share at Daehan Synthet are growing +41.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Daehan Synthet (003830) generate?
The free cash flow of Daehan Synthet is −11.6B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Daehan Synthet (003830) carry?
The net debt of Daehan Synthet is 6.4B KRW (fiscal year 2019). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Daehan Synthet in the live analysis
One click puts Daehan Synthet on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
